Pharmaceutical Companies

Global pharmaceutical giant known for vaccines (COVID-19, pneumonia), oncology drugs, and cardiovascular medications. 175+ years in business.

#1 pharma company by 2024 Rx revenue ($53.5B). Janssen pharmaceutical division focuses on immunology, oncology, and neuroscience.

Danish pharmaceutical leader in diabetes care and obesity treatments. Makers of Ozempic, Wegovy, and Rybelsus. +26% revenue growth in 2024.

Fastest-growing major pharma (+32% in 2024). Makers of Mounjaro, Zepbound, and affordable insulin. Industry leader in patient assistance.

#2 pharma by 2024 Rx revenue ($52.7B). Known for immunology blockbusters Humira, Skyrizi, Rinvoq. Best-in-class patient support for rheumatology.

British-Swedish pharma with +18% growth in 2024 ($54.1B revenue). Strong in oncology, respiratory, and cardiovascular medications.

Global pharmaceutical company. Makers of Keytruda (revolutionary cancer immunotherapy), Gardasil (HPV vaccine), and essential medications.

Pioneer biotech company (+17% growth in 2024). Leaders in biologics for cancer, bone health, and inflammatory conditions.

Leader in HIV treatment and prevention (Biktarvy, Descovy for PrEP). Also strong in hepatitis C cures and oncology.

Innovative biotech known for Eylea (eye disease), Dupixent (eczema/asthma, with Sanofi), and COVID-19 antibody treatments.

Powerhouse in cancer treatment (Opdivo, Yervoy, Revlimid) and blood disorders. Strong patient access support programs.

British pharmaceutical company leading in vaccines (Shingrix, flu), respiratory medications, and HIV treatments (ViiV Healthcare).

French pharmaceutical company known for Dupixent (with Regeneron), diabetes care (Lantus), vaccines, and rare disease treatments.